[1] |
Wen DG, Shan BE, Zhang SW, et al. Analysis of incidence and mortality rates of bladder cancer in registration areas of China from 2003 to 2007[J]. Zhong Liu,2012,32(4):256-62. [温登瑰, 单保恩,张思维,等,2003—2007年中国肿瘤登记地区膀胱 癌的发病与死亡分析[J]. 肿瘤, 2012,32(4):256-62.]
|
[2] |
Oosterlinck W, Decaestecker K. Current strategies in the treatment of non-muscle-invasive bladder cancer[J]. Expert Rev Anticancer Ther,2012,12(8):1097-106.
|
[3] |
Cui Y, Wang ML. Research in human cytomegalovirus infection and cancer[J]. Wei Sheng Wu Yu Gan Ran,2008,3(3):166-9.[崔 寰,王明丽.人巨细胞病毒感染与肿瘤相关性研究进展[J]. 微生 物与感染,2008,3(3):166-9.]
|
[4] |
Yang N,Chen HL,Qian X,et al. Analysis of Nanchang qualifi ed blood donors with human cytomegalovirus infection[J]. Zhongguo Shu Xue Za Zhi,2012,25(11):1193-4.[杨南,陈火玲,钱 献,等.南昌市合格无偿献血者人巨细胞病毒感染情况分析[J]. 中国输血杂志,2012,25(11):1193-4.]
|
[5] |
Huang LS,Sheng CH,Lin MS. Investigate in Shantou blood donors with HCMV[J]. Guangzhou Yi Yao,2009,40(5):63-4.[黄 蓝生,盛楚华,林美珊. 汕头市健康无偿献血人群HCMV感染调 查[J] 广州医药,2009,40(5):63-4.]
|
[6] |
Zhou YF, Fang F. Molecular mechanisms of HCMV in immune escape[J]. Guo Wai Yi Xue (Bing Du Xue Fen Ce), 2004, 11 (2):43-6. [周玉峰,方峰. HCMV免疫逃避分子机制研究进展 [J] 国外医学(病毒学分册),2004,11(2):43-6.]
|
[7] |
Moutaftsi M, Mehl AM, Borysiewicz LK, et al. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells[J]. Blood, 2002, 99(8):2913-21.
|
[8] |
Hansen SG, Powers CJ, Richards R, et al. Evasion of CD8+ T cells is critical for super-infection by cytomegalovirus[J]. Scince, 20 10,328(5974):102-6.
|
[9] |
Kawai K, Miyazaki J, Joraku A,et al. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine[J].Cancer Sci,2013,104(1):22-7.
|
[10] |
Zuiverloon TC, Nieuweboer AJ, Vékony H, et al. Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review[J]. Eur Urol,2012,61(1):128-45.
|
[11] |
Shintani Y, Sawada Y, Inagaki T, et al. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy[J]. Int J Urol,2007,14(2):140-6.
|
[12] |
Shi HQ,Ge J,Tang L,et al. The correlation study of HCMV active infection and urothelial carcinoma[J]. Anhui Yi Ke Da Xue Xue Bao,2013,48(1):60-5.[施浩强,葛俊,唐亮,等. HCMV 活动性感染与尿路上皮癌的相关性研究[J].安徽医科大学学 报,2013,48(1):60-5.]
|